U.S. Hospitality Stock News

Analyst reaction to Phase 1 trial progress Piper Sandler and Barclays recently updated their views on CytomX Therapeutics (CTMX) after promising Phase 1 data for varsetatug maseatecan in metastatic colorectal cancer, highlighting renewed investor attention ahead of further clinical readouts. See our latest analysis for CytomX Therapeutics. The share price, which last closed at US$6.07, has seen a 42.82% year to date share price return and a very large 1 year total shareholder return,...

BeOne Medicines (NasdaqGS:ONC) received its first regulatory clearance for BCL2 inhibitor sonrotoclax, supporting clinical development in chronic lymphocytic leukemia. The company extended its collaboration with InSysBio to apply translational modeling for dose selection and cytokine release syndrome risk management in future studies. BeOne Medicines focuses on oncology drug development. Sonrotoclax is now moving into a new regulatory phase that puts more attention on its BCL2 approach in...

AMETEK (AME) has just posted another set of quarterly numbers, with Q3 FY 2025 revenue at US$1,892.6 million and basic EPS of US$1.61 setting the tone for the year so far. The company has seen revenue move from US$1,708.6 million in Q3 FY 2024 to US$1,892.6 million in Q3 FY 2025. Over the same quarters, basic EPS went from US$1.47 to US$1.61, supported by trailing twelve month EPS of US$6.36 on revenue of about US$7.2 billion. Taken together with a trailing net margin of 20.5% versus 19.3% a...

Pfizer (PFE) has just posted its FY 2025 third quarter numbers, reporting revenue of US$16.7b and basic EPS of US$0.62, with trailing twelve month EPS at US$1.73. The company has seen revenue move from US$17.8b in Q4 2024 to US$13.7b in Q1 2025 and US$14.7b in Q2 2025, while quarterly EPS shifted from US$0.07 to US$0.52 and US$0.51 over the same stretch. This feeds into a 15.6% net profit margin over the last 12 months compared with 7.0% a year earlier, giving investors a clearer view of how...

EXL, a global data and AI company, was recently named a Leader for Payer Digital Transformation Services in the ISG Provider Lens Healthcare Digital Services – US 2025 study, marking its fourth consecutive recognition in this category. This repeated Leader status underscores EXL’s combination of artificial intelligence, data, and cloud capabilities with deep healthcare payer expertise to modernize complex operational systems. Next, we’ll examine how this continued leadership in payer digital...

Community Financial System, Inc. has reported past fourth-quarter 2025 results, with net interest income rising to US$133.43 million and net income reaching US$54.42 million, alongside basic and diluted earnings per share from continuing operations of US$1.03. The period also saw net charge-offs fall to US$2,328,000 and the board affirm a quarterly cash dividend of US$0.47 per share, underscoring an emphasis on both credit quality and shareholder returns. We’ll now examine how the...

If you are wondering whether Northrop Grumman at around US$704.98 is offering fair value or stretching expectations, this article is designed to help you make sense of the numbers. The stock has returned 3.9% over the last 7 days, 20.4% over the past month and year to date, 48.7% over 1 year, 63.9% over 3 years, and 152.0% over 5 years. These figures naturally raise questions about what is already priced in and where the risk might sit for new investors. Recent coverage around Northrop...

Investors may be wondering whether Napco Security Technologies, at around US$43.74, is still a sensible entry or addition to a portfolio, or if most of the value story is already reflected in the price. The stock has moved sharply at times, with returns of 13.7% over the last 7 days, 5.7% over the last 30 days, 5.7% year to date, 68.3% over the last year, 27.3% over 3 years, and 198.1% over 5 years. This naturally raises questions about risk and reward at today's level. Recent attention on...

Hess Midstream (HESM) has just wrapped up FY 2025 with fourth quarter revenue of US$404.2 million, basic EPS of US$0.72 and net income of US$93.3 million, capping a year in which trailing twelve month revenue reached US$1.6 billion and EPS came in at US$2.87. Over the last year, revenue has moved from US$1.5 billion to about US$1.6 billion on a trailing basis, while trailing twelve month net income has gone from US$223.1 million to US$352.9 million. This gives investors a clear view of how...

UiPath (NYSE:PATH) is emerging as a leader in agentic AI, a field focused on software agents that can autonomously complete complex, multi step tasks. The company reports strong customer adoption for its agentic AI capabilities, with high retention rates across its user base. UiPath is expanding in the public sector, including work with the U.S. Coast Guard and the Social Security Administration. These developments are drawing attention as potential drivers of investor sentiment toward...

In recent months, analysts have updated their views on LifeStance Health Group, pointing to changing expectations around the company’s prospects. This comes as LifeStance reported revenue growth of 16.34% as of September 30, 2025, underscoring momentum in its top-line performance. With this backdrop of analyst attention and revenue expansion, we’ll examine how these developments shape LifeStance Health Group’s broader investment narrative. Outshine the giants: these 25 early-stage AI...

Graphic Packaging Holding (GPK) has just posted its FY 2025 third quarter numbers, with revenue of about US$2.2 billion, basic EPS of US$0.48 and net income of US$142 million, while trailing 12 month figures show revenue of US$8.6 billion, EPS of US$1.70 and net income of US$511 million. Over the past few quarters, revenue has moved in a tight band from US$2.09 billion in Q4 2024 to between US$2.12 billion and US$2.20 billion through 2025, while quarterly EPS has ranged from US$0.35 to...

W.W. Grainger (GWW) opened FY 2025 with third quarter revenue of US$4.7b and basic EPS of US$6.15, set against a trailing twelve month line of US$17.8b in revenue and EPS of US$35.93. The company has seen quarterly revenue move from US$4.31b in Q2 2024 to US$4.55b in Q2 2025, and from US$4.39b in Q3 2024 to US$4.66b in Q3 2025, while basic EPS has ranged from roughly US$9.59 to US$10.04 across those prior quarters. With a net margin that has eased from 10.8% to 9.7% over the last year, this...

Alpha Metallurgical Resources recently issued preliminary unaudited guidance indicating it expects to report a net loss of US$17.3 million, or US$1.34 per diluted share, for the fourth quarter of 2025, and confirmed it has repurchased 113,000 shares for US$20 million in the final quarter of 2025. This update highlights a rare quarterly loss for a company that has emphasized conservative capital allocation and has retired over 43% of its shares since March 2022. We’ll examine how the...

If you are wondering whether Builders FirstSource at around US$118 still offers solid value, or if most of the opportunity is already priced in, this article is designed to help you assess that for yourself. The stock has a 7 day return of 1.1%, a 30 day and year to date return of 13.3%, but a 1 year return showing a 27.5% decline, so recent moves look very different depending on the time frame you focus on. Recent market attention has been shaped by ongoing interest in US housing and...

Rithm Capital (RITM) has put up a steady run of numbers heading into FY 2025, with third quarter revenue at US$943 million and basic EPS of US$0.36, alongside trailing twelve month revenue of about US$4.0 billion and EPS of US$1.47. The company has seen quarterly revenue move between US$646 million and US$1.3 billion over the last six reported periods, with basic EPS ranging from US$0.07 to US$0.54. This sets a clear backdrop for how investors might read the current US$10.95 share price...

RPC (RES) has just posted its FY 2025 third quarter scorecard, reporting revenue of $447.1 million and basic EPS of $0.06. This puts fresh numbers on the table after a run of mixed earnings over the past year. The company’s revenue has moved from $364.2 million in FY 2024 Q2 to $337.7 million in Q3 and $335.4 million in Q4, then to $332.9 million, $420.8 million and now $447.1 million through FY 2025. Over the same stretch, quarterly EPS shifted from $0.15 to $0.09, $0.06, $0.06, $0.05 and...

If you are wondering whether Newell Brands' current share price reflects its true worth, you are not alone. This article walks through what the latest data says about value. The stock most recently closed at US$4.40, with returns of 0.9% over 7 days and 18.3% over both the last 30 days and year to date, against a longer term record that includes a 52.0% decline over 1 year, 67.4% over 3 years and 79.4% over 5 years. Those mixed returns sit against a backdrop of ongoing attention on Newell...

In late January 2026, Glaukos Corporation received FDA approval for an NDA labeling supplement that permits repeat administration of its long-duration iDose TR glaucoma implant, supported by clinical data showing safe and well-tolerated second treatments over 12 months. This decision effectively positions iDose TR as a potentially longer-term, repeatable treatment option aimed at reducing non-compliance and side effects linked to traditional eye-drop therapies for glaucoma. Next, we will...

Why Lionsgate Studios Stock Is Drawing Attention Now Lionsgate Studios (LION) has caught investor attention after recent trading left the share price at US$8.98, with returns ranging from a 3.4% decline over the month to a 33.2% gain in the past 3 months. See our latest analysis for Lionsgate Studios. Recent trading has been choppy, with a 1-day share price return of 2.7% decline and a 7-day share price return of 6.2% decline. However, the 90-day share price return of 33.2% suggests momentum...

East West Bancorp (NasdaqGS:EWBC) announced a 33% increase in its quarterly dividend. The higher dividend follows the company’s latest annual and quarterly results, which management described as strong. The move signals an increased cash return to shareholders through the regular dividend. East West Bancorp is a commercially focused bank with a footprint that connects U.S. and Asia linked clients, serving businesses and individuals across a range of lending and deposit services. For...

CorVel (CRVL) has just wrapped up Q3 2026 with its recent numbers anchored by the latest reported quarter, where revenue in Q2 2026 was US$239.6 million and basic EPS came in at US$0.54. This feeds into trailing 12 month EPS of US$2.05 and net income of US$105.3 million. Over the recent reporting periods, the company has seen revenue move from US$224.4 million in Q2 2025 to US$239.6 million in Q2 2026, with basic EPS stepping from US$0.46 to US$0.54 over the same quarters. This sets up a...

Capital Southwest (CSWC) just posted Q3 2026 results with total revenue of US$61.4 million and basic EPS of US$0.57, setting the tone for another data rich update on its earnings power. The company has seen quarterly revenue move from US$51.9 million in Q3 2025 to US$61.4 million in Q3 2026, while basic EPS shifted from US$0.34 to US$0.57 over the same period. This gives investors a clear sense of how the top and bottom lines have trended into this quarter. With a trailing 12 month net profit...

Speculative surge puts TechCreate Group (TCGL) in the spotlight TechCreate Group (TCGL) has been thrust into the market spotlight after a very large short term share price spike, including volatility halts, largely linked to speculative trading and momentum driven sentiment. See our latest analysis for TechCreate Group. With TechCreate Group’s share price now at $172.84 after a 1 day share price return of around 100% and a very large 30 day gain, the move caps a powerful short term run that...